K&F’s first post-pandemic jury trial resulted in a $10.6 million verdict for the widow of a mesothelioma victim.

Ranitidine recalls continue, but don’t get the press they need

On Behalf of | Mar 25, 2020 | Zantac Recall

Along with everyone else in the country, Ohio residents have bigger concerns than what is happening with heartburn medications. However, it is still important to keep up to date on ranitidine recalls, especially for those who are having issues due to stress. Some people may be surprised to learn that testing and the investigation into the presence of N-Nitrosodimethylamine, or NDMA, continues regardless of what else may be going on right now.

As a result of the ongoing investigation, yet another manufacturer is recalling medications containing ranitidine due to excessive levels of NDMA. American Health Packaging recently issued a voluntary recall of certain lots of its heartburn medication when testing revealed elevated levels of this probably human carcinogen. Many Ohio residents will recall that high levels of this chemical can lead to a variety of cancers.

Even though NDMA is found in foods and water, it is the levels in these medications that raises concerns. Some people remain on these medications for years to treat digestive issues such as duodenal ulcers, gastric ulcers and more. Research indicates that over time, this contaminant can adversely affect the health of some patients. Right now, there seems to be no real safe form of ranitidine, which has been the “go to” medication for heartburn and other ailments for decades.

Even though companies are not reporting any adverse events in connection with these ranitidine recalls, many people are coming forward indicating that they believe their cancer diagnosis resulted from the use of these medications. It will more than likely take some time to prove this connection in court. However, that should not necessarily deter affected individuals from pursuing the restitution they need and deserve.

Archives

$120 Million Settlement

To 15,000 Asbestos Victims

$20 Million Verdict

Mesothelioma

$17 Million Verdict

Mesothelioma

$8.2 Million Verdict

Mesothelioma

White Paper Read Now2
White Paper Read Now